In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Elan licenses Anesta Actiq

Executive Summary

Elan Pharmaceuticals has licensed exclusive rights to Anesta Corp.'s oral transmucosal fentanyl products, including oral transmucosal fentanyl citrate Actiq, in Austria, Belgium, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Philippines, Switzerland, Taiwan, and the UK.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Concluded
Deal Type
  • Alliance
    • Includes Contract
    • R&D and Marketing (Licensing)

Related Companies